Skip to main content
Caplight Logo









Amphasys

Amphasys

Private
RootHealthcare & Life Scienceshttps://amphasys.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amphasys is a biotechnology company that provides advanced solutions for high-precision, single-cell analysis using impedance flow cytometry for applications in the agriculture and bioprocessing industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

impedance flow cytometrylabel-free cell analysissingle-cell analysiscell viability analysismicrofluidic chipsbioprocess monitoringpollen analysisAgriTechprocess analytical technologyPATseed techplant breedingbiosensorbiotech equipmentrazor and blades modelfermentation monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amphasys Comparables

Compare Amphasys with similar companies based on industry and business-model similarity.

Amphasys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SBT Instruments
83%
Yokogawa Electric Corporation
66%
Sysmex Corporation
62%

Amphasys Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Marco Di Berardino

CTO

Executive Team

Luca De Villa Palù

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 53% MoM.

  • Jul 3, 2025

    Monthly visitors grew 60% MoM.

Amphasys Filings

Explore SEC and related filing metadata, where available.

Amphasys filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amphasys's valuation, stock price, and market status.

Is Amphasys a public or private company?

Amphasys is a private company.

What is the current stock price of Amphasys?

Amphasys is a private company with no public stock price. No recent secondary market data is available.

How much is Amphasys worth (valuation)?

Valuation information for Amphasys is not publicly available.

Can I buy Amphasys stock?

Amphasys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amphasys's last funding round?

Funding round information for Amphasys is not publicly available.

Who are the main investors in Amphasys?

Investor information for Amphasys is not publicly disclosed.

Will Amphasys IPO soon?

No public IPO plans have been announced for Amphasys.

How can I track Amphasys secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amphasys's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRoot
Employee Range18
Year Founded2012
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?